| Literature DB >> 29866034 |
Daniel C Schroeder1, Alexandra C Maul2, Esther Mahabir3, Isabell Koxholt3, Xiaowei Yan4, Stephan A Padosch4, Holger Herff4, Insa Bultmann-Mellin2, Anja Sterner-Kock2, Thorsten Annecke4, Tim Hucho4, Bernd W Böttiger4, Maria Guschlbauer2,5.
Abstract
BACKGROUND: Contribution of the small intestine to systemic inflammation after cardiac arrest (CA) is poorly understood. The objective was to evaluate whether an in vivo rat model of 6 min CA is suitable to initiate intestinal ischaemia-reperfusion-injury and to evaluate histomorphological changes and inflammatory processes in the small intestinal mucosa resp. in sera.Entities:
Keywords: Cardiac arrest; Ischaemia-reperfusion-injury; Small intestine; Systemic inflammatory response syndrome
Mesh:
Substances:
Year: 2018 PMID: 29866034 PMCID: PMC5993127 DOI: 10.1186/s12871-018-0530-8
Source DB: PubMed Journal: BMC Anesthesiol ISSN: 1471-2253 Impact factor: 2.217
Number of rats used for histomorphological analysis (HA) and cytokine profiling (CP) of controls (C) and at 6 h, 24 h, 72 h and 7 d post-ROSC
| Study groups and number of rats | |||||
|---|---|---|---|---|---|
| Analysis | C | 6 h | 24 h | 72 h | 7 d |
| Jejunum HA | 4 | 3 | 5 | 4 | 4 |
| Jejunum CP | 4 | 3 | 5 | 6 | 4 |
| Serum CP | 6 | 3 | 6 | 4 | 4 |
This analysis is a sub-study of an investigation aimed to pursue systemic inflammation in multiple tissues after CA. Serum cytokine profiling was conducted in n = 23 rats. Only n = 3 animals were resuscitated and included in the 6 h group. At least n = 4 animals were included in the 24 h, 72 h and 7 d group. Additionally, n = 2 more sera in the control group and 1 more serum sample in the 24 h group were collected and analyzed from further experiments. In the 72 h group, n = 2 more jejunal samples were also analyzed
Fig. 1Histomorphological evaluation of the jejunal wall of rats after 6 min of CA using a modified Chiu scoring system (Chiu et al. 1970) [44]. Images represent the Chiu grades 0–5. a Intact mucosa and villus structures in control tissue of sham-operated rats (Chiu grade 0). b Development of a sub-epithelial space at the tips of the villi (arrow) 24 h post-ROSC (Chiu grade 1). c Development of a Gruenhagen’s space at the tip of a villus (arrow) 24 h post-ROSC (Chiu grade 2). d Villus necrosis (arrow) 7 d post-ROSC (Chiu grade 3). e Massive epithelial desquamation and villi which are denuded of epithelial layer (arrow) 7 d post-ROSC (Chiu grade 4). f Loss of villi, mucosal ulceration and necrosis 7 d post-ROSC (Chiu grade 5). a-f Hematoxilin-eosin staining, longitudinal section of 4 μm thickness (a, e, f) or cross section (b, c, d), scale bars represent 100 μm
Fig. 2Chiu Scoring. Chiu Scoring [Grades 0–5] in jejunum of controls and at 6 h, 24 h, 72 h and 7 d post-ROSC are expressed as mean ± SD. One-way ANOVA p < 0.0001. Tukey’s multiple comparison test is marked with asterisks (*p < 0.05, ***p < 0.001, ****p < 0.0001)
Fig. 3Cytokine concentrations of IL-1α, IL-1β, IL-6, IL-10 and TNF-α (mean ± SD, pg/ml) in jejunum (left column) and serum (right column) in controls and at 6 h, 24 h, 72 h and 7 d post-ROSC. The significance of Tukey’s multiple comparison test is marked with asterisks (*p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001). a IL-1α concentrations in jejunum (one-way ANOVA p < 0.01). b IL-1β concentrations in jejunum (one-way ANOVA p < 0.01). c IL-6 concentrations in jejunum (one-way ANOVA p < 0.01). d IL-10 concentrations in jejunum (one-way ANOVA p < 0.0001). e TNF-α concentrations in jejunum (one-way ANOVA p < 0.01). f IL-1α concentrations in serum (one-way ANOVA p > 0.05). g IL-1β concentrations in serum (one-way ANOVA*). h IL-6 concentrations in serum (one-way ANOVA p > 0.05). i IL-10 concentrations in serum (one-way ANOVA p > 0.05). j TNF-α concentrations in serum (one-way ANOVA p > 0.05)
Absolute levels of cytokines in serum (IL-2, IL-4, IL-5, IL-12 (p70), IL-13, GM-CSF, IFN-γ) in controls (C) and at 6 h, 24 h, 72 h and 7d post-ROSC expressed in pg/ml (mean ± SD)
| C | 6 h | 24 h | 72 h | 7d | |
|---|---|---|---|---|---|
| IL-2 | 0.36 ± 0.35 | 0.27 ± 0.06 | 0.20 ± 0.05 | 0.21 ± 0.07 | 0.34 ± 0.28 |
| IL-4 | 0.24 ± 0.18 | 0.22 ± 0.09 | 0.17 ± 0.02 | 0.17 ± 0.02 | 0.23 ± 0.10 |
| IL-5 | n.d. | n.d. | n.d. | n.d. | n.d. |
| IL-12 (p70) | n.d. | n.d. | n.d. | n.d. | n.d. |
| IL-13 | n.d. | n.d. | n.d. | n.d. | n.d. |
| GM-CSF | 0.20 ± 0.01 | 0.25 ± 0.06 | 0.23 ± 0.02 | 0.24 ± 0.03 | 0.23 ± 0.05 |
| IFN-γ | 0.36 ± 0.07 | 0.47 ± 0.18 | 0.34 ± 0.01 | 0.31 ± 0.02 | 0.35 ± 0.05 |
n.d. not detected
Ratio of absolute IL-1α, IL-1β, IL-6, IL-10, TNF-α levels in jejunum to absolute levels in serum in controls (C) and at 6 h, 24 h, 72 h and 7d post-ROSC (mean ± SD)
| C | 6 h | 24 h | 72 h | 7d | |
|---|---|---|---|---|---|
| IL-1α | 15.2 ± 3.6**** | 15.5 ± 1.7**** | 30.4 ± 3.8**** | 19.3 ± 4*** | 13.9 ± 5**** |
| IL-1β | 1.7 ± 0.2* | 1 ± 0.6 | 6.9 ± 0.4** | 7.9 ± 2.9 | 10.2 ± 1.5 |
| IL-6 | 1 ± 0.1 | 1 ± 0.04 | 1.3 ± 0.03**** | 1 ± 0.02 | 1.1 ± 0.1 |
| IL-10 | 1.9 ± 0.4 | 1.8 ± 0.3 | 4.2 ± 0.6**** | 3.6 ± 0.5* | 2.5 ± 0.7 |
| TNF-α | 1.5 ± 0.04**** | 1.4 ± 0.1* | 2.1 ± 0.1*** | 1.7 ± 0.2* | 2 ± 0.1** |
The level of significance is marked with asterisks: *p < 0.05, **p < 0.01 ***p < 0.001, ****p < 0.0001)